Immuno-Oncology Program

330 Brookline Avenue
Boston, MA 02215
Phone: 617-667-2100

Using Immuno-Oncology to Treat Cancer

Biologic Therapy Research for Cancer Treatment

Our Immuno-Oncology Program is internationally recognized for contributions to the biologic treatment of cancer using cytokines (IL-2,1 FN), targeted immunotherapy (CTLA4 and PD1 antibodies), vaccines and other novel agents. Our Immuno-Oncology Program specialists, including Drs. David McDermott, James Mier and Rupal Bhatt, investigate and use biologic agents, such as cytokines and vaccines, to treat patients with advanced melanoma and kidney cancer.

More About Us Meet Our Team

More About Immuno-Oncology

Immuno-Oncology Clinical Trials

Our program conducts pivotal clinical trials that have led to FDA approval for therapies for metastatic kidney cancer and melanoma (skin cancer). 

Prepare for Your Visit

To help you prepare for your first visit to our Cancer Center's Immuno-Oncology Clinic, read these FAQs on what to expect. 

Immuno-Oncology Research

We specialize in kidney cancer research, working to find better methods of early detection and treatment for renal cell carcinoma.

Request an Appointment

Ready to get started? Call or go online today.

P 617-667-2100